Cargando…
Predictors of the Use of Mineralocorticoid Receptor Antagonists in Patients With Left Ventricular Dysfunction Post‐ST‐Segment–Elevation Myocardial Infarction
BACKGROUND: Guidelines recommend mineralocorticoid receptor antagonist (MRA) use in patients with left ventricular ejection fraction ≤40% following a myocardial infarction plus heart failure or diabetes mellitus, based on mortality benefit in the EPHESUS (Eplerenone Post‐Acute Myocardial Infarction...
Autores principales: | Wong, Eric C., Fordyce, Christopher B., Wong, Graham, Lee, Terry, Perry‐Arnesen, Michele, Mackay, Martha, Singer, Joel, Cairns, John A., Turgeon, Ricky D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483484/ https://www.ncbi.nlm.nih.gov/pubmed/34227405 http://dx.doi.org/10.1161/JAHA.120.019167 |
Ejemplares similares
-
Impact of Patient- and System-Level Delays on Reperfusion Among Patients With ST-Elevation Myocardial Infarction
por: Wenner, Joshua B., et al.
Publicado: (2020) -
Care and Outcomes of ST-Segment Elevation Myocardial Infarction Across Multiple COVID-19 Waves
por: Malhi, Navraj, et al.
Publicado: (2022) -
Association of pre‐hospital time intervals and clinical outcomes in ST‐elevation myocardial infarction patients
por: Mackay, Martha H., et al.
Publicado: (2022) -
Impact of regionalizing ST‐elevation myocardial infarction care on sex differences in reperfusion times and clinical outcomes
por: Rayner‐Hartley, Erin, et al.
Publicado: (2021) -
Access-Site vs Non-Access-Site Major Bleeding and In-Hospital Outcomes Among STEMI Patients Receiving Primary PCI
por: Thibert, Michael J., et al.
Publicado: (2021)